Patients who have experienced a perinatal loss are at increased risk of MDD, anxiety disorders, and trauma-related disorders.
News
This article explains the role of medications that have high affinity to block dopamine D4.
"The national day had dawned."
“People in glass houses shouldn’t throw stones.”
The medication treatment of schizophrenia has finally diversified to a novel neurotransmitter system: the muscarinic cholinergic system.
While still following the Goldwater Rule, how can psychiatrists help improve mental health following the election?
How can psychiatric clinicians help their patients (and themselves) identify and navigate the aftermath of the election?
We need psychiatrists now more than ever...
New positive results demonstrate the efficacy and safety of lumateperone (Caplyta) 42 mg for the prevention of relapse in adult patients with schizophrenia.
How can we ensure an accountable, effective, and limited conservatorship system? Here are some actionable concepts.
This is a month to celebrate!
Learn more about a specific subset of mood disorders.
Is love blind? A psychiatrist analyzes the viral reality tv experiment.
It’s Election Day. What lingering traumas are we still processing as a country?
A psychiatrist shares reflections via a note to America.
A new collaboration to address sleep disturbances associated with cognitive impairment, an unmet need.
How can we lessen fatal interactions between individuals with mental illness and police? The best possible avenue is partnership and cooperation between mental health clinicians and law enforcement.
A refined rTMS protocol, the Stanford Accelerated Intelligent Neuromodulation Therapy for major depressive disorder, shows promise in bipolar disorder.
The importance of holidays…
Here's why you should attend Real Psychiatry!
Do you want to be featured in our online series and potentially in print? Check out our November theme!
"I am overtired, Of the great harvest I myself desired."
How should we choose our leaders?
Posters from the conference confirm the durability of long-term treatment with xanomeline/trospium (Cobenfy).
A final argument on psychiatric diagnoses.
How can you as clinicians balance a patient’s right to autonomy with beneficence?
How can the type of treatment affect the potential development and maintenance of genuine resilience?
This Halloween, we should be scared of sexism.